Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec:113:113-115.
doi: 10.1016/j.ijid.2021.09.069. Epub 2021 Sep 29.

Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19

Affiliations

Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19

Giuseppe Sberna et al. Int J Infect Dis. 2021 Dec.

Abstract

Diagnostic methods based on SARS-CoV-2 antigen detection are a promising alternative to SARS-CoV-2 RNA amplification. We evaluated the automated chemiluminescence-based Lumipulse® G SARS-CoV-2 Ag assay as compared to real time assays (combined results from RT-PCR Allplex™ SARS-CoV-2 assay and Easy SARS-CoV-2 WE kit) on 513 nasopharyngeal swabs (NPS). Among these, 53.6% resulted positive to RT-PCR, considered as the reference test. Compared to the reference test, overall sensitivity and specificity of Lumipulse® G SARS-CoV-2 Ag assay were 84.0%, and 89.1%, respectively, and overall agreement between the antigen and molecular assays was substantial (κ = 0.727). When stratifying samples into groups based on ranges of RT-PCR cycle threshold (Ct), the antigen test sensitivity was >95% for samples with Ct <30. Linear regression analysis showed strong and highly significant correlation between the Lumipulse Ag concentrations and the RT-PCR Ct values (RdRp gene), irrespective of whether the Ct values from molecular test were combined in a unique regression analysis or analysed separately. Overall, chemiluminescence-based antigen assay may be reliably applied to NPS samples to identify individuals with high viral loads, more likely to transmit the virus.

Keywords: Antigen assay; COVID-19; Lumipulse; RT-PCR; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1
Figure 1
(A) SARS-CoV-2 N antigen concentration in 257 samples positive to the Lumipulse® G SARS-CoV-2 Ag assay, grouped according to the number of genes resulted positive by RT-PCR: confirmed with complete set of genes, i.e. to 3 genes with the Allplex™ SARS-CoV-2 assay and to 2 genes with the Easy SARS-CoV-2 WE assay (median: 3.11 Log pg/mL); confirmed with incomplete set of genes, i.e. to 2 genes with the Allplex™ SARS-CoV-2 assay and to 1 gene with the Easy SARS-CoV-2 WE assay (median: 0.57 Log pg/mL); not confirmed (median: 0.28 Log pg/mL). Statistically significant differences in Student´s T test are indicated in the figure. (B) Correlation between Lumipulse Ag concentrations (Log pg/mL) and Ct values of RdRp gene from the RT-PCR combined results of Allplex™ SARS-CoV-2 Assay and Easy SARS-CoV-2 WE kit (n=513). (C and D) Correlation between Lumipulse Ag concentrations (Log pg/mL) and Ct values of RdRp gene split for from the Allplex™ SARS-CoV-2 Assay (n=387, C) and for the Easy SARS-CoV-2 WE kit (n=126, D). Samples with Ct <40 or pg/mL ≥1.34pg/mL were considered positive. For statistical calculations, an arbitrary value of 41 Ct was assigned to all RT-PCR negative samples and an arbitrary value of 1.0 pg/mL was assigned to all samples with Ag concentration <1.0 pg/mL.

Similar articles

Cited by

References

    1. Amendola A, Sberna G, Lalle E, Colavita F, Castilletti C, Menchinelli G, et al. Saliva is a valid alternative to Nasopharyngeal Swab in Chemiluminescence-based assay for detection of SARS-CoV-2 Antigen. J Clin Med. 2021 Apr 2;10(7):1471. doi: 10.3390/jcm10071471. - DOI - PMC - PubMed
    1. Bordi L, Parisi G, Sberna G, Amendola A, Mariani B, Meoni G, et al. Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: A pilot project. J Infect. 2021;83(1):e8–e10. doi: 10.1016/j.jinf.2021.05.013. Jul. - DOI - PMC - PubMed
    1. Hirotsu Y, Maejima M, Shibusawa M, Amemiya K, Nagakubo Y, Hosaka K, et al. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR. Int J Infect Dis. Apr 2021;105:7–14. doi: 10.1016/j.ijid.2021.02.005. - DOI - PMC - PubMed
    1. Hirotsu Y, Sugiura H, Maejima M, Hayakawa M, Mochizuki H, Tsutsui T, et al. Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19. Int J Infect Dis. Jun 1 2021;108:263–269. doi: 10.1016/j.ijid.2021.05.067. - DOI - PMC - PubMed
    1. Kobayashi R, Murai R, Asanuma K, Fujiya Y, Takahashi S. Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen. J Infect Chemother. Jun 27 2021;(6):800–807. doi: 10.1016/j.jiac.2021.01.007. Epub 2021 Jan 16. - DOI - PMC - PubMed